Skip to Content

XL184 80mg (Cometriq 80 mg)

Generic Name: cabozantinib

Pill with imprint XL184 80mg is Orange, Capsule-shape and has been identified as Cometriq 80 mg. It is supplied by Exelixis, Inc..

Cometriq is used in the treatment of thyroid cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Cometriq 80 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for XL184 80mg

Cometriq

Generic Name
cabozantinib
Imprint
XL184 80mg
Strength
80 mg
Color
Orange
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Multikinase inhibitors, VEGF/VEGFR inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Exelixis, Inc.
National Drug Code (NDC)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.